Pfizer Inc Allogene Therapeutics, Inc. (ALLO) insider trading activity

ALLO Quotes by TradingView

Pfizer Inc is > 10% Shareholder of Allogene Therapeutics, Inc.. Currently has a direct ownership of 22 Million shares of ALLO, which is worth approximately $46.5 Million. The most recent transaction as insider was on Oct 15, 2018, when has been sold 55,556 shares (Common Stock) at a price of $18.0 per share, resulting in proceeds of $1,000,008. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22M
0% 3M change
0% 12M change
Total Value Held $46.5 Million

PFIZER INC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 15 2018
BUY
Open market or private purchase
$1,000,008 $18.0 p/Share
55,556 Added 0.25%
22,032,040 Common Stock
Oct 15 2018
BUY
Conversion of derivative security
-
21,976,484 Added 50.0%
21,976,484 Common Stock

Also insider at

VTRS
Viatris Inc Healthcare
> 10% Shareholder
CERE
Cerevel Therapeutics Holdings, Inc. Healthcare
ICUI
ICU MEDICAL INC Healthcare
Director
SWTX
SpringWorks Therapeutics, Inc. Healthcare
> 10% Shareholder
BCAB
BioAtla, Inc. Healthcare
> 10% Shareholder
PYXS
Pyxis Oncology, Inc. Healthcare
> 10% Shareholder
CRTX
Cortexyme, Inc. Healthcare
> 10% Shareholder
IMRA
IMARA Inc. Healthcare
> 10% Shareholder
PI

Pfizer Inc

> 10% Shareholder
New York, NY

Track Institutional and Insider Activities on ALLO

Follow Allogene Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALLO shares.

Notify only if

Insider Trading

Get notified when an Allogene Therapeutics, Inc. insider buys or sells ALLO shares.

Notify only if

News

Receive news related to Allogene Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALLO